Loading…

Should ebselen be considered for the treatment of mercury intoxication? A minireview

Mercury is a ubiquitous environmental contaminant and can be found in inorganic (Hg , Hg and Hg ) and organic forms (chiefly CH Hg or MeHg ). The main route of human, mammals and bird exposure occurs predatory fish ingestion. Occupational exposure to Hg (and Hg ) can also occur; furthermore, in gold...

Full description

Saved in:
Bibliographic Details
Published in:Toxicology mechanisms and methods 2024, Vol.34 (1), p.1-12
Main Authors: Barbosa, Nilda V, Aschner, Michael, Tinkov, Alexey A, Farina, Marcelo, Rocha, João Batista Teixeira da
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c365t-90f0b289d78d8ba1a156a5c6d5efcf14ea90fbaedea86bf93d714a7b52f87f453
cites cdi_FETCH-LOGICAL-c365t-90f0b289d78d8ba1a156a5c6d5efcf14ea90fbaedea86bf93d714a7b52f87f453
container_end_page 12
container_issue 1
container_start_page 1
container_title Toxicology mechanisms and methods
container_volume 34
creator Barbosa, Nilda V
Aschner, Michael
Tinkov, Alexey A
Farina, Marcelo
Rocha, João Batista Teixeira da
description Mercury is a ubiquitous environmental contaminant and can be found in inorganic (Hg , Hg and Hg ) and organic forms (chiefly CH Hg or MeHg ). The main route of human, mammals and bird exposure occurs predatory fish ingestion. Occupational exposure to Hg (and Hg ) can also occur; furthermore, in gold mining areas the exposure to inorganic Hg can also be high. The toxicity of electrophilic forms of Hg (E Hg) is mediated by disruption of thiol (-SH)- or selenol (-SeH)-containing proteins. The therapeutic approaches to treat methylmercury (MeHg ), Hg and Hg are limited. Here we discuss the potential use of ebselen as a potential therapeutic agent to lower the body burden of Hg in man. Ebselen is a safe drug for humans and has been tested in clinical trials (for instance, brain ischemia, noise-induce hearing loss, diabetes complications, bipolar disorders) at doses varying from 400 to 3600 mg per day. Two clinical trials with ebselen in moderate and severe COVID are also approved. Ebselen can be metabolized to an intermediate with -SeH (selenol) functional group, which has a greater affinity to electrophilic Hg (E Hg) forms than the available thiol-containing therapeutic agents. Accordingly, as observed and rodent models Ebselen exhibited protective effects against MeHg , indicating its potential as a therapeutic agent to treat MeHg overexposure. The combined use of ebselen with thiol-containing molecules (e.g. N-acetylcysteine and enaramide)) is also commented, because they can have synergistic protective effects against MeHg .
doi_str_mv 10.1080/15376516.2023.2258958
format article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_10841883</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2867148875</sourcerecordid><originalsourceid>FETCH-LOGICAL-c365t-90f0b289d78d8ba1a156a5c6d5efcf14ea90fbaedea86bf93d714a7b52f87f453</originalsourceid><addsrcrecordid>eNpVUclOwzAQtRCIluUTQD5ySbHj2HFPCCE2qRIH4Gw59pgaJXGxE5a_JxGhgsvMaJb3nuYhdELJghJJzilnpeBULHKSs0Wec7nkcgfNx34meF7sbmsqZuggpVdCqKQF3UczVpaMMs7m6OlxHfraYqgS1NDiCrAJbfIWIljsQsTdGnAXQXcNtB0ODjcQTR-_sG-78OmN7nxoL_AlbnzrI7x7-DhCe07XCY6nfIieb66fru6y1cPt_dXlKjNM8C5bEkeqXC5tKa2sNNWUC82NsByccbQAPWxUGixoKSq3ZLakhS4rnjtZuoKzQ3Txg7vpqwasGQRGXatN9I2OXypor_5PWr9WL-FdDR8sqJRsQDibEGJ46yF1qvHJQF3rFkKfVC7FwCllOZLxn1UTQ0oR3JaHkhFwCJMlarRETZYMd6d_RW6vfj1g32TRib8</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2867148875</pqid></control><display><type>article</type><title>Should ebselen be considered for the treatment of mercury intoxication? A minireview</title><source>Taylor and Francis:Jisc Collections:Taylor and Francis Read and Publish Agreement 2024-2025:Medical Collection (Reading list)</source><creator>Barbosa, Nilda V ; Aschner, Michael ; Tinkov, Alexey A ; Farina, Marcelo ; Rocha, João Batista Teixeira da</creator><creatorcontrib>Barbosa, Nilda V ; Aschner, Michael ; Tinkov, Alexey A ; Farina, Marcelo ; Rocha, João Batista Teixeira da</creatorcontrib><description>Mercury is a ubiquitous environmental contaminant and can be found in inorganic (Hg , Hg and Hg ) and organic forms (chiefly CH Hg or MeHg ). The main route of human, mammals and bird exposure occurs predatory fish ingestion. Occupational exposure to Hg (and Hg ) can also occur; furthermore, in gold mining areas the exposure to inorganic Hg can also be high. The toxicity of electrophilic forms of Hg (E Hg) is mediated by disruption of thiol (-SH)- or selenol (-SeH)-containing proteins. The therapeutic approaches to treat methylmercury (MeHg ), Hg and Hg are limited. Here we discuss the potential use of ebselen as a potential therapeutic agent to lower the body burden of Hg in man. Ebselen is a safe drug for humans and has been tested in clinical trials (for instance, brain ischemia, noise-induce hearing loss, diabetes complications, bipolar disorders) at doses varying from 400 to 3600 mg per day. Two clinical trials with ebselen in moderate and severe COVID are also approved. Ebselen can be metabolized to an intermediate with -SeH (selenol) functional group, which has a greater affinity to electrophilic Hg (E Hg) forms than the available thiol-containing therapeutic agents. Accordingly, as observed and rodent models Ebselen exhibited protective effects against MeHg , indicating its potential as a therapeutic agent to treat MeHg overexposure. The combined use of ebselen with thiol-containing molecules (e.g. N-acetylcysteine and enaramide)) is also commented, because they can have synergistic protective effects against MeHg .</description><identifier>ISSN: 1537-6516</identifier><identifier>EISSN: 1537-6524</identifier><identifier>DOI: 10.1080/15376516.2023.2258958</identifier><identifier>PMID: 37731353</identifier><language>eng</language><publisher>England</publisher><subject>Animals ; Azoles - therapeutic use ; Humans ; Mammals - metabolism ; Mercury - toxicity ; Methylmercury Compounds - metabolism ; Methylmercury Compounds - toxicity ; Sulfhydryl Compounds</subject><ispartof>Toxicology mechanisms and methods, 2024, Vol.34 (1), p.1-12</ispartof><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c365t-90f0b289d78d8ba1a156a5c6d5efcf14ea90fbaedea86bf93d714a7b52f87f453</citedby><cites>FETCH-LOGICAL-c365t-90f0b289d78d8ba1a156a5c6d5efcf14ea90fbaedea86bf93d714a7b52f87f453</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>230,314,780,784,885,4024,27923,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/37731353$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Barbosa, Nilda V</creatorcontrib><creatorcontrib>Aschner, Michael</creatorcontrib><creatorcontrib>Tinkov, Alexey A</creatorcontrib><creatorcontrib>Farina, Marcelo</creatorcontrib><creatorcontrib>Rocha, João Batista Teixeira da</creatorcontrib><title>Should ebselen be considered for the treatment of mercury intoxication? A minireview</title><title>Toxicology mechanisms and methods</title><addtitle>Toxicol Mech Methods</addtitle><description>Mercury is a ubiquitous environmental contaminant and can be found in inorganic (Hg , Hg and Hg ) and organic forms (chiefly CH Hg or MeHg ). The main route of human, mammals and bird exposure occurs predatory fish ingestion. Occupational exposure to Hg (and Hg ) can also occur; furthermore, in gold mining areas the exposure to inorganic Hg can also be high. The toxicity of electrophilic forms of Hg (E Hg) is mediated by disruption of thiol (-SH)- or selenol (-SeH)-containing proteins. The therapeutic approaches to treat methylmercury (MeHg ), Hg and Hg are limited. Here we discuss the potential use of ebselen as a potential therapeutic agent to lower the body burden of Hg in man. Ebselen is a safe drug for humans and has been tested in clinical trials (for instance, brain ischemia, noise-induce hearing loss, diabetes complications, bipolar disorders) at doses varying from 400 to 3600 mg per day. Two clinical trials with ebselen in moderate and severe COVID are also approved. Ebselen can be metabolized to an intermediate with -SeH (selenol) functional group, which has a greater affinity to electrophilic Hg (E Hg) forms than the available thiol-containing therapeutic agents. Accordingly, as observed and rodent models Ebselen exhibited protective effects against MeHg , indicating its potential as a therapeutic agent to treat MeHg overexposure. The combined use of ebselen with thiol-containing molecules (e.g. N-acetylcysteine and enaramide)) is also commented, because they can have synergistic protective effects against MeHg .</description><subject>Animals</subject><subject>Azoles - therapeutic use</subject><subject>Humans</subject><subject>Mammals - metabolism</subject><subject>Mercury - toxicity</subject><subject>Methylmercury Compounds - metabolism</subject><subject>Methylmercury Compounds - toxicity</subject><subject>Sulfhydryl Compounds</subject><issn>1537-6516</issn><issn>1537-6524</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2024</creationdate><recordtype>article</recordtype><recordid>eNpVUclOwzAQtRCIluUTQD5ySbHj2HFPCCE2qRIH4Gw59pgaJXGxE5a_JxGhgsvMaJb3nuYhdELJghJJzilnpeBULHKSs0Wec7nkcgfNx34meF7sbmsqZuggpVdCqKQF3UczVpaMMs7m6OlxHfraYqgS1NDiCrAJbfIWIljsQsTdGnAXQXcNtB0ODjcQTR-_sG-78OmN7nxoL_AlbnzrI7x7-DhCe07XCY6nfIieb66fru6y1cPt_dXlKjNM8C5bEkeqXC5tKa2sNNWUC82NsByccbQAPWxUGixoKSq3ZLakhS4rnjtZuoKzQ3Txg7vpqwasGQRGXatN9I2OXypor_5PWr9WL-FdDR8sqJRsQDibEGJ46yF1qvHJQF3rFkKfVC7FwCllOZLxn1UTQ0oR3JaHkhFwCJMlarRETZYMd6d_RW6vfj1g32TRib8</recordid><startdate>2024</startdate><enddate>2024</enddate><creator>Barbosa, Nilda V</creator><creator>Aschner, Michael</creator><creator>Tinkov, Alexey A</creator><creator>Farina, Marcelo</creator><creator>Rocha, João Batista Teixeira da</creator><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>2024</creationdate><title>Should ebselen be considered for the treatment of mercury intoxication? A minireview</title><author>Barbosa, Nilda V ; Aschner, Michael ; Tinkov, Alexey A ; Farina, Marcelo ; Rocha, João Batista Teixeira da</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c365t-90f0b289d78d8ba1a156a5c6d5efcf14ea90fbaedea86bf93d714a7b52f87f453</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2024</creationdate><topic>Animals</topic><topic>Azoles - therapeutic use</topic><topic>Humans</topic><topic>Mammals - metabolism</topic><topic>Mercury - toxicity</topic><topic>Methylmercury Compounds - metabolism</topic><topic>Methylmercury Compounds - toxicity</topic><topic>Sulfhydryl Compounds</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Barbosa, Nilda V</creatorcontrib><creatorcontrib>Aschner, Michael</creatorcontrib><creatorcontrib>Tinkov, Alexey A</creatorcontrib><creatorcontrib>Farina, Marcelo</creatorcontrib><creatorcontrib>Rocha, João Batista Teixeira da</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Toxicology mechanisms and methods</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Barbosa, Nilda V</au><au>Aschner, Michael</au><au>Tinkov, Alexey A</au><au>Farina, Marcelo</au><au>Rocha, João Batista Teixeira da</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Should ebselen be considered for the treatment of mercury intoxication? A minireview</atitle><jtitle>Toxicology mechanisms and methods</jtitle><addtitle>Toxicol Mech Methods</addtitle><date>2024</date><risdate>2024</risdate><volume>34</volume><issue>1</issue><spage>1</spage><epage>12</epage><pages>1-12</pages><issn>1537-6516</issn><eissn>1537-6524</eissn><abstract>Mercury is a ubiquitous environmental contaminant and can be found in inorganic (Hg , Hg and Hg ) and organic forms (chiefly CH Hg or MeHg ). The main route of human, mammals and bird exposure occurs predatory fish ingestion. Occupational exposure to Hg (and Hg ) can also occur; furthermore, in gold mining areas the exposure to inorganic Hg can also be high. The toxicity of electrophilic forms of Hg (E Hg) is mediated by disruption of thiol (-SH)- or selenol (-SeH)-containing proteins. The therapeutic approaches to treat methylmercury (MeHg ), Hg and Hg are limited. Here we discuss the potential use of ebselen as a potential therapeutic agent to lower the body burden of Hg in man. Ebselen is a safe drug for humans and has been tested in clinical trials (for instance, brain ischemia, noise-induce hearing loss, diabetes complications, bipolar disorders) at doses varying from 400 to 3600 mg per day. Two clinical trials with ebselen in moderate and severe COVID are also approved. Ebselen can be metabolized to an intermediate with -SeH (selenol) functional group, which has a greater affinity to electrophilic Hg (E Hg) forms than the available thiol-containing therapeutic agents. Accordingly, as observed and rodent models Ebselen exhibited protective effects against MeHg , indicating its potential as a therapeutic agent to treat MeHg overexposure. The combined use of ebselen with thiol-containing molecules (e.g. N-acetylcysteine and enaramide)) is also commented, because they can have synergistic protective effects against MeHg .</abstract><cop>England</cop><pmid>37731353</pmid><doi>10.1080/15376516.2023.2258958</doi><tpages>12</tpages></addata></record>
fulltext fulltext
identifier ISSN: 1537-6516
ispartof Toxicology mechanisms and methods, 2024, Vol.34 (1), p.1-12
issn 1537-6516
1537-6524
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_10841883
source Taylor and Francis:Jisc Collections:Taylor and Francis Read and Publish Agreement 2024-2025:Medical Collection (Reading list)
subjects Animals
Azoles - therapeutic use
Humans
Mammals - metabolism
Mercury - toxicity
Methylmercury Compounds - metabolism
Methylmercury Compounds - toxicity
Sulfhydryl Compounds
title Should ebselen be considered for the treatment of mercury intoxication? A minireview
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-26T03%3A03%3A13IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Should%20ebselen%20be%20considered%20for%20the%20treatment%20of%20mercury%20intoxication?%20A%20minireview&rft.jtitle=Toxicology%20mechanisms%20and%20methods&rft.au=Barbosa,%20Nilda%20V&rft.date=2024&rft.volume=34&rft.issue=1&rft.spage=1&rft.epage=12&rft.pages=1-12&rft.issn=1537-6516&rft.eissn=1537-6524&rft_id=info:doi/10.1080/15376516.2023.2258958&rft_dat=%3Cproquest_pubme%3E2867148875%3C/proquest_pubme%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c365t-90f0b289d78d8ba1a156a5c6d5efcf14ea90fbaedea86bf93d714a7b52f87f453%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2867148875&rft_id=info:pmid/37731353&rfr_iscdi=true